名媛直播

"Safety net" providers who serve low-income Medicare beneficiaries would get an extra pay bump

In trial, datopotamab deruxtecan increased progression-free survival by 2 months

The alleged unwarranted procedures on former patients date back to 2010

And 40.5% noted efficacy claims not listed on the labels of their originator products

News, features, and commentary about cancer-related issues

CDK4/6 inhibitor extended progression-free survival by nearly 15 months in phase III trial

Several Republican-led states pursued the case following Supreme Court decision preserving access

Researchers speculate that impaired nutritional status could account for preclinical loss in BMI

名媛直播 reporters offer further insights into recently covered topics

Health news and commentary gathered by 名媛直播 staff

One congresswoman named the future of vaccines as one of her biggest concerns

Dual diagnosis comes with increased risks of mortality, heart failure hospitalization

No disparity emerges, though, in discussing weight-loss surgery with a healthcare provider

Agency also issues final rule for 6-month buprenorphine prescriptions issued over the phone

Strike lines are "strong and getting stronger," union says

Study's unexpected findings have parallels to observations in elite athletes

Mortality hazard reduced by one third at 7 years versus trastuzumab

While well tolerated, there was also no significant reduction in risk of recurrence over placebo